Gordon Bates
🏛️ Revolving DoorFormer Government Positions:
CoS, Sen. McConnell, 2000-02; Legal Cnsl, Sen. McConnell, 1999-00; Chief Cnsl, Senate Rules Committee, 1997-99.
CoS, Sen. McConnell, 2000-02; Legal Cnsl, Sen. McConnell, 1999-00
🤖
AI Overview
Gordon Bates has appeared in 704 federal lobbying filings at Akin Gump Strauss Hauer & Feld, representing 50 clients. As a former government official, they bring insider expertise to their lobbying work — part of Washington's "revolving door." Active across 45 policy areas.
704
Total Filings
1
Firms
50
Clients
45
Issue Areas
Issue Areas
Filing History
| Year | Filings | Clients |
|---|---|---|
| 2018 | 111 | 32 |
| 2019 | 127 | 33 |
| 2020 | 126 | 36 |
| 2021 | 48 | 17 |
| 2022 | 62 | 23 |
| 2023 | 79 | 22 |
| 2024 | 79 | 25 |
| 2025 | 72 | 21 |
Firms
Akin Gump Strauss Hauer & Feld704 filings
Top Clients
University of Louisville47 filings
Doordash39 filings
Lyft, INC.29 filings
Biotechnology Innovation Organization28 filings
Altria Client Services LLC26 filings
Air Evac Lifeteam25 filings
United Parcel Service25 filings
National Thoroughbred Racing Association24 filings
Amgen USA, INC.22 filings
Fletcher Group, INC.22 filings
Southeastern Conference22 filings
Bamboo Health19 filings
Alliance for Automotive Innovation18 filings
Gilead Sciences INC16 filings
Gila River Indian Community14 filings
Global Laser Enrichment, LLC14 filings
AT&T Services, INC. (FKA AT&T)13 filings
Related Analysis
Related Investigations
The Revolving Door Exposed
How former government officials become the most powerful lobbyists.
The 22,000% ROI
When lobbying spending yields outsized returns.
The Crypto Lobbying Explosion
How crypto went from zero to massive lobbying presence.
The 2025 Tariff Panic
As tariffs return, lobbying on trade surges.
Big Tech's $150M Lobbying War
Tech giants battle over AI, antitrust, privacy, and trade.
Big Pharma's $452M Lobbying Machine
How pharmaceutical companies spend hundreds of millions to influence health policy.
Explore More
Data Sources: Senate LDA Filings
Last updated: February 2026
This site is an independent journalism project. Analysis and editorial content are not affiliated with or endorsed by any government agency.